406 related articles for article (PubMed ID: 19796706)
1. Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms.
Chavez JA; Summers SA
Biochim Biophys Acta; 2010 Mar; 1801(3):252-65. PubMed ID: 19796706
[TBL] [Abstract][Full Text] [Related]
2. Ceramides - Lipotoxic Inducers of Metabolic Disorders.
Chaurasia B; Summers SA
Trends Endocrinol Metab; 2015 Oct; 26(10):538-550. PubMed ID: 26412155
[TBL] [Abstract][Full Text] [Related]
3. Ceramides in Metabolism: Key Lipotoxic Players.
Chaurasia B; Summers SA
Annu Rev Physiol; 2021 Feb; 83():303-330. PubMed ID: 33158378
[TBL] [Abstract][Full Text] [Related]
4. The Lard Works in Mysterious Ways: Ceramides in Nutrition-Linked Chronic Disease.
Nicholson RJ; Norris MK; Poss AM; Holland WL; Summers SA
Annu Rev Nutr; 2022 Aug; 42():115-144. PubMed ID: 35584813
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.
Meikle PJ; Summers SA
Nat Rev Endocrinol; 2017 Feb; 13(2):79-91. PubMed ID: 27767036
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.
Holland WL; Summers SA
Endocr Rev; 2008 Jun; 29(4):381-402. PubMed ID: 18451260
[TBL] [Abstract][Full Text] [Related]
7. Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity.
Yoon H; Shaw JL; Haigis MC; Greka A
Mol Cell; 2021 Sep; 81(18):3708-3730. PubMed ID: 34547235
[TBL] [Abstract][Full Text] [Related]
8. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage.
Raz I; Eldor R; Cernea S; Shafrir E
Diabetes Metab Res Rev; 2005; 21(1):3-14. PubMed ID: 15386813
[TBL] [Abstract][Full Text] [Related]
9. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
Lewis GF; Carpentier A; Adeli K; Giacca A
Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
[TBL] [Abstract][Full Text] [Related]
10. Triglycerides, fatty acids and insulin resistance--hyperinsulinemia.
Kraegen EW; Cooney GJ; Ye J; Thompson AL
Exp Clin Endocrinol Diabetes; 2001; 109(4):S516-26. PubMed ID: 11453039
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipids: players in the pathology of metabolic disease.
Cowart LA
Trends Endocrinol Metab; 2009 Jan; 20(1):34-42. PubMed ID: 19008117
[TBL] [Abstract][Full Text] [Related]
12. Sphingolipids and glycerophospholipids - The "ying and yang" of lipotoxicity in metabolic diseases.
Rodriguez-Cuenca S; Pellegrinelli V; Campbell M; Oresic M; Vidal-Puig A
Prog Lipid Res; 2017 Apr; 66():14-29. PubMed ID: 28104532
[TBL] [Abstract][Full Text] [Related]
13. Ectopic lipid storage and insulin resistance: a harmful relationship.
Borén J; Taskinen MR; Olofsson SO; Levin M
J Intern Med; 2013 Jul; 274(1):25-40. PubMed ID: 23551521
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells.
Bandet CL; Tan-Chen S; Bourron O; Le Stunff H; Hajduch E
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678043
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
16. Review: Lipid biology in the periparturient dairy cow: contemporary perspectives.
McFadden JW
Animal; 2020 Mar; 14(S1):s165-s175. PubMed ID: 32024571
[TBL] [Abstract][Full Text] [Related]
17. DES1: A Key Driver of Lipotoxicity in Metabolic Disease.
Blitzer JT; Wang L; Summers SA
DNA Cell Biol; 2020 May; 39(5):733-737. PubMed ID: 32181687
[TBL] [Abstract][Full Text] [Related]
18. Intramyocellular fat storage in metabolic diseases.
Laurens C; Moro C
Horm Mol Biol Clin Investig; 2016 Apr; 26(1):43-52. PubMed ID: 26741351
[TBL] [Abstract][Full Text] [Related]
19. [Molecular alterations induced by fructose and its impact on metabolic diseases].
Loza-Medrano SS; Baiza-Gutman LA; Ibáñez-Hernández MÁ; Cruz-López M; Díaz-Flores M
Rev Med Inst Mex Seguro Soc; 2019 Jan; 56(5):491-504. PubMed ID: 30777418
[TBL] [Abstract][Full Text] [Related]
20. Free fatty acids and skeletal muscle insulin resistance.
Kraegen EW; Cooney GJ
Curr Opin Lipidol; 2008 Jun; 19(3):235-41. PubMed ID: 18460913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
